GINER INC SBIR Phase I Award,

A SBIR Phase I contract was awarded to Giner, Inc. for $299,966.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

Overview Structured Data Issues Contributors Activity

sbir.gov/node/2580413

Is a

SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient

Giner, Inc.

Government Agency

Government Branch

National Institutes of Health

Award Type

SBIR0

Contract Number (US Government)

75N93023C000200

Award Phase

Phase I0

Award Amount (USD)

299,9660

Abstract

Point-of-Care HIV Viral Load, Drug Resistance, and Adherence Assays: The long-term goals of this program are to develop novel, low-cost, real-time point-of-care (POC) assays for 1. HIV Viral Load Monitoring; 2. HIV Drug Resistance Monitoring; and 3. Pharmacological Adherence Monitoring. This contract aims to develop an electrochemical POC test that will enable direct and label-free measurement of antiretroviral drugs in blood and urine samples.